Healthcare Realty Trust Inc Q1 2022 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Omotayo Tejamude Okusanya - CrTdit Suisse AG, Research Division - Analyst : I want to talk a little bit about the strategic combination and this viewpoint you guys have put out that you will be able to accelerate your FAD per share growth to about 5% to 7% once the acquisition is done. I guess the question for me is, can HR on its own get to that level of FAD per share growth given some of these factors or drivers you're talking about, multi-tenant occupancy increases, rent growth, redevelopment? Those are all things you guys are planning to accelerate anyway as a stand-alone entity. So why do you need the deal to get to that number? It sounds like you may be able to get to that level of acceleration by yourselves. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. MAY 05, 2022 / 4:00PM, HR.N - Q1 2022 Healthcare Realty Trust Inc Earnings Call

Question: Omotayo Tejamude Okusanya - CrTdit Suisse AG, Research Division - Analyst : Okay. That's very helpful. And then one more, if you could indulge me. So the revenue synergy is, again, not baked into any of your numbers. I think on the slide, you guys kind of talk about them very theoretically and what they could be, and they make sense. But any sense in general from a quantification perspective what that could do to potential FAD per share growth or what that could do to potential accretion from the deal, kind of on a very high level, if you get some of that for the next 15 months?